Tessa Fotoohi
Physician Assistant · Everett, WANPI 1821360934
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,274 of the $7,123 with a category attached, or 88.1%. It is spread thinly across 41 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Eli Lilly$1K
- AstraZeneca$579
- Novo Nordisk$481
- Pfizer$399
- Lilly USA, LLC$383
- plus $3K from 35 others
What the payments were for
- Travel & lodging$74911%
- Food & beverage$6,27488%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,327 |
| Eli Lilly | 12 | $1,065 |
| AstraZeneca | 24 | $579 |
| Novo Nordisk | 23 | $481 |
| Pfizer | 22 | $399 |
| Lilly USA, LLC | 29 | $383 |
| Corcept Therapeutics | 14 | $312 |
| GSK | 15 | $278 |
| Bayer | 4 | $273 |
| Mylan Specialty L.p. | 11 | $203 |
| Astellas Pharma US Inc | 6 | $200 |
| Dexcom, Inc. | 8 | $171 |
| Merck | 9 | $166 |
| Novartis | 6 | $139 |
| Sanofi-aventis U.S. LLC | 6 | $89 |
| Boehringer Ingelheim | 4 | $87 |
| Amgen | 5 | $81 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Viatris Specialty LLC | 5 | $79 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Gilead | 3 | $64 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| Lundbeck LLC | 3 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Cleerly, Inc. | 1 | $50 |
| Eisai Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Exact Sciences | 2 | $31 |
| Medtronic | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Photonicare Inc | 1 | $21 |
| Halozyme Inc | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Teleflex LLC | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,123 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 39 | $57,341 |
| OzempicSemaglutide | 32 | $41,416 |
| Repatha SureclickEvolocumab | 14 | $14,357 |
| VeozahFezolinetant | 12 | $6,289 |
| Estradiol | 18 | $3,271 |
| SynthroidLevothyroxine Sodium | 17 | $1,547 |
| Rosuvastatin Calcium | 83 | $1,040 |
| Levothyroxine Sodium | 149 | $1,018 |
| Irbesartan | 23 | $901 |
| Atorvastatin Calcium | 75 | $764 |
| Potassium Chloride | 23 | $633 |
| Gabapentin | 31 | $558 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $522 |
| Duloxetine Hcl | 22 | $520 |
| Pantoprazole Sodium | 46 | $487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $383 | $57,34139 claims |
| Novo NordiskOzempic | $481 | $41,41632 claims |
| Astellas Pharma US IncVeozah | $200 | $6,28912 claims |
| AbbVieSynthroid | $1,327 | $1,54717 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $14 | $1,018149 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Everett
- Shelene YoshidaEverett$7K
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
- Justin ChapinSeattle$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.